Authors : Islam Omar Abdel Fattah, Wael Amin Nasr El‐Din
DOI : 10.1002/ar.24519
Volume : 304
Issue : 4
Year : 2021
Page No : 787-802
AbstractIntervertebral disc degeneration (IVDD) is a major contributor to low back pain (LBP). Granulocyte‐colony stimulating factor (GCSF) is known to mobilize hematopoietic stem cells (HSCs) that may be implicated in intervertebral disc (IVD) regeneration. Rats were divided into the following three groups: (i) control group; (ii) IVDD group—the rats underwent Co5/Co6 and Co7/Co8 IVDD operation; and (iii) GCSF‐treated group—the rats received daily GCSF subcutaneous injections starting 6 weeks after the IVDD operation and continued for 5 days. All of the rats were euthanized after 8 weeks, and IVDs were assessed by tail X‐ray and histopathological, immunohistochemical, and transmission electron microscopy (TEM) analyses. The X‐rays showed disc narrowing in the IVDD group that was significantly widened in the GCSF‐treated rats. Histologically, the IVDD group showed disarrangement of the annulus fibrosis lamellae, complete degeneration of the nucleus pulposus, and loss of proteoglycan content. These changes were improved after GCSF treatment. Vertebral endplate thickness and cellularity were significantly decreased with IVDD and significantly increased after GCSF treatment. Stromal cell‐derived factor‐1α (SDF‐1α) immune expression was significantly increased in the IVDD group but decreased in the GCSF‐treated group. However, the caspase‐3 expression percentage showed no significant difference among the studied groups. TEM showed excessive collagen deposits around the notochordal cells in the IVDD group, which were attenuated in the GCSF‐treated group. These results indicate that GCSF improves IVDD and promotes its recovery based on radiological, histological and TEM findings.